Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People

Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People

311200

Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People

A single dose of NVG-291, a potential nerve repair therapy for multiple sclerosis (MS), was safe and well-tolerated among healthy volunteers in a Phase 1 safety trial, and was found to have favorable pharmacological properties, new data show. Given the positive results thus far, a safety committee supervising the study has recommended that NervGen, the therapy’s developer, begin the multiple ascending dose (MAD) phase of the trial. To date, the single ascending dose (SAD) part of…

You must be logged in to read/download the full post.